In 2018, Mohammad Razzan was diagnosed with brain cancer when he was only 10 years old. The results of the CT scan and MRI showed a medulloblastoma type. His neurologist recommended surgery, but it was risky as it involved pressure on the brainstem and cerebellum. His general doctor then sought an alternative using ECCT. His condition progressed relatively smoothly, with his complaints gradually disappearing as he went through an intense detoxification process in the first month of using the ECCT device. His pain disappeared, and his motor skills and body balance returned to normal. His parents, both working in the hospital, were initially afraid to take him to see his neurosurgeon again or undergo another MRI, worried that the results would not match Razzan’s condition, which seemed fine. However, after using the device for 6 years and seeing his condition remain stable, his parents finally decided to undergo an MRI, and the result was CLEAR—there was no sign of cancer left in Razzan’s brain. The cancer, which had grown in his brainstem and blocked the brain’s channels, was completely cleared without surgery, just with ECCT.
Far right: CT scan showing a tumor mass in the periventricular area of the fourth ventricle, indicating medulloblastoma with extensive edema throughout the brain, alongside an ECVT scan showing high activity in the brainstem and left cerebellum, correlating with elevated intracranial pressure. Second from the right: MRI after 6 years of ECCT treatment showing a normal brain condition, with no detected masses (CLEAR). Second from the left: ECVT brain scan showing abnormal activity in the initial mass area, but increased abnormal activity in the pineal area, commonly correlated with vagus nerve activation due to digestive disturbances, consistent with Razzan’s complaints of frequent stomach aches/ulcers.
Far left: Razzan’s photo with Dr. Warsito at the end of 2024, showing Razzan’s healthy condition and normal growth.
At first, Razzan complained of dizziness, feeling as if his head was spinning after playing with a gadget for a long time, followed by vomiting that lasted for a week and didn’t respond to medication. A CT scan and MRI confirmed the medulloblastoma diagnosis. His neurologist recommended surgery, but it was risky because of the pressure on the brainstem and cerebellum. His general doctor then sought an alternative treatment using ECCT.
Medulloblastoma is a malignant brain tumor that originates in the lower back part of the brain called the cerebellum, which is responsible for motor coordination, balance, and movement. Medulloblastoma cells grow rapidly and can spread to other parts of the brain through cerebrospinal fluid that surrounds and protects the brain and spinal cord.
Medulloblastoma can occur at any age, but it is most common in young children and is one of the most common types of brain cancer in children. It is more prevalent in families with a history of conditions that increase the risk of cancer. Symptoms occur when the tumor grows or causes pressure buildup in the brain, leading to symptoms such as nausea, vomiting, dizziness, and balance disturbances.
Patients diagnosed with this cancer have a mortality rate 50 times higher than the average population. The average survival rate for this cancer is 60% at 5 years and 52% at 10 years for all ages. The survival rate in children is relatively higher, reaching 69% for a 5-year survival rate.
Medulloblastoma cancer has a rapid proliferation rate, and the response to ECCT is equally fast. The faster the tumor grows, the quicker the cells die when exposed to the electric field generated by the ECCT device. The location near the primary drainage path, the fourth ventricle, is particularly helpful for clearing dead cells, which flow through the cerebrospinal fluid pathways into the intestines and are excreted with feces. Razzan experienced an intense detox reaction, including very foul-smelling black stools for several days after the first month of ECCT treatment. As this extreme detox reaction occurred, Razzan’s pain and other symptoms gradually disappeared, and his motor skills and body balance returned to normal.
After 6 years, Razzan’s condition was very good, his activities were normal, and his growth was on track. He is currently busy with his studies in high school.
We wish Razzan continued good health. (WS)
